This is a good point too. Part of the reason, IMO, that our prices are so high is because they are kept low by legislation in European countries and such.
Put another way, the U.S. subsidizes R&D for other parts of the world.
It’s definitely a balancing act though - the companies shouldn’t be price gouging patients but they also need to be able to recoup development costs.
News 
Market Data 
Discover 
